Sarepta Therapeutics Inc banner

Sarepta Therapeutics Inc
NASDAQ:SRPT

Watchlist Manager
Sarepta Therapeutics Inc Logo
Sarepta Therapeutics Inc
NASDAQ:SRPT
Watchlist
Price: 21.9 USD -5.11% Market Closed
Market Cap: $2.3B

Wall Street
Price Targets

SRPT Price Targets Summary
Sarepta Therapeutics Inc

Wall Street analysts forecast SRPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SRPT is 30.27 USD with a low forecast of 5.05 USD and a high forecast of 194.25 USD.

Lowest
Price Target
5.05 USD
77% Downside
Average
Price Target
30.27 USD
38% Upside
Highest
Price Target
194.25 USD
787% Upside
Sarepta Therapeutics Inc Competitors:
Price Targets
TENB
Tenable Holdings Inc
71% Upside
MRVL
Marvell Technology Group Ltd
6% Upside
ESQ
Esquire Financial Holdings Inc
8% Upside
8841
TOC Co Ltd
25% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
-5% Downside
VINP
Vinci Partners Investments Ltd
38% Upside
NN
NextNav Inc
40% Upside

Revenue
Forecast

32% / Year
Past Growth
-12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
32% / Year
Past Growth
-12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Sarepta Therapeutics Inc's revenue is 32%. The projected CAGR for the next 3 years is -12%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SRPT's stock price target?
Price Target
30.27 USD

According to Wall Street analysts, the average 1-year price target for SRPT is 30.27 USD with a low forecast of 5.05 USD and a high forecast of 194.25 USD.

What is Sarepta Therapeutics Inc's Revenue forecast?
Projected CAGR
-12%

For the last 14 years the compound annual growth rate for Sarepta Therapeutics Inc's revenue is 32%. The projected CAGR for the next 3 years is -12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett